Category Archives: Uncategorized

This phase 3 study assessed the safety and efficacy of satralizumab monotherapy for neuromyelitis optica spectrum disorder (NMOSD). Source: AAO

• Posted on: Jul 1 2020
• By: Saratoga Opthalmology
• Leave a response

The authors discuss the appropriate personal protective equipment (PPE) requirements for surgeons as well as the usage, availability and rationing of materials during the COVID-19 pandemic. Source: AAO

• Posted on: Jun 30 2020
• By: Saratoga Opthalmology
• Leave a response

This retrospective single-center case series reports the characteristics and outcomes of pediatric patients with keratoconus who underwent corneal crosslinking (CXL) under general anesthesia. Source: AAO

• Posted on: Jun 29 2020
• By: Saratoga Opthalmology
• Leave a response

This week, a patient with COVID-19 experiences orbital emphysema, scientists provide a peek into how hummingbirds distinguish colors and new studies challenge researchers’ understanding of retinitis pigmentosa 59. Source: AAO

• Posted on: Jun 26 2020
• By: Saratoga Opthalmology
• Leave a response

This survey study sought to investigate the perceived educational impact of podcasts and other materials on the general retina community. Source: AAO

• Posted on: Jun 25 2020
• By: Saratoga Opthalmology
• Leave a response

This prospective, randomized clinical trial compared the efficacy and safety of 3 fragmentation patterns in eyes undergoing femtosecond laser-assisted cataract surgery (FLACS). Source: AAO

• Posted on: Jun 24 2020
• By: Saratoga Opthalmology
• Leave a response

This study evaluated the optic nerve sheath diameter in eyes with dysthyroid optic neuropathy. Source: AAO

• Posted on: Jun 23 2020
• By: Saratoga Opthalmology
• Leave a response

Researchers from Duke University assessed whether N95 respirators could be decontaminated using hydrogen peroxide vapor. Source: AAO

• Posted on: Jun 22 2020
• By: Saratoga Opthalmology
• Leave a response

This week, several ophthalmic drugs appear on the FDA’s shortage list, a vitamin A analog shows promise for early diabetic retinopathy and an SMS texting system could streamline patient encounters during the pandemic. Source: AAO

• Posted on: Jun 19 2020
• By: Saratoga Opthalmology
• Leave a response

Inebilizumab (Uplizna) has been cleared for neuromyelitis optica spectrum disorder (NMOSD). The monotherapy drug is now the first and only B cell-depleting antibody approved for the disease. Source: AAO

• Posted on: Jun 18 2020
• By: Saratoga Opthalmology
• Leave a response